Mangoceuticals, Common Stock Stock Price History
MGRX Stock | 2.50 0.03 1.19% |
If you're considering investing in Mangoceuticals, Stock, it is important to understand the factors that can impact its price. As of today, the current price of Mangoceuticals, Common stands at 2.50, as last reported on the 1st of December, with the highest price reaching 2.58 and the lowest price hitting 2.48 during the day. Mangoceuticals, Common has Sharpe Ratio of -0.11, which conveys that the firm had a -0.11% return per unit of risk over the last 3 months. Mangoceuticals, Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mangoceuticals, Common's Standard Deviation of 5.87, mean deviation of 4.19, and Risk Adjusted Performance of (0.02) to check out the risk estimate we provide.
Other Stockholder Equity is likely to rise to about 12.6 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 503.1 K in 2024. . At this time, Mangoceuticals, Common's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 8.03 in 2024, whereas Price To Sales Ratio is likely to drop 7.70 in 2024. Mangoceuticals, Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Mangoceuticals, |
Sharpe Ratio = -0.1105
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | MGRX |
Estimated Market Risk
5.5 actual daily | 48 52% of assets are more volatile |
Expected Return
-0.61 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Mangoceuticals, Common is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mangoceuticals, Common by adding Mangoceuticals, Common to a well-diversified portfolio.
Price Book 0.4643 | Enterprise Value Ebitda (0.51) | Price Sales 7.2577 | Shares Float 1.4 M | Earnings Share (5.70) |
Mangoceuticals, Common Stock Price History Chart
There are several ways to analyze Mangoceuticals, Stock price data. The simplest method is using a basic Mangoceuticals, candlestick price chart, which shows Mangoceuticals, Common price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 1, 2024 | 4.47 |
Lowest Price | November 1, 2024 | 2.26 |
Mangoceuticals, Common December 1, 2024 Stock Price Synopsis
Various analyses of Mangoceuticals, Common's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Mangoceuticals, Stock. It can be used to describe the percentage change in the price of Mangoceuticals, Common from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Mangoceuticals, Stock.Mangoceuticals, Common Price Daily Balance Of Power | (0.30) | |
Mangoceuticals, Common Price Action Indicator | (0.04) | |
Mangoceuticals, Common Price Rate Of Daily Change | 0.99 |
Mangoceuticals, Common December 1, 2024 Stock Price Analysis
Mangoceuticals, Stock Price History Data
The price series of Mangoceuticals, Common for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 2.21 with a coefficient of variation of 22.24. The daily prices for the period are spread out with arithmetic mean of 3.06. The median price for the last 90 days is 2.76. The company underwent 1:15 stock split on 16th of October 2024.Open | High | Low | Close | Volume | ||
12/01/2024 | 2.58 | 2.58 | 2.48 | 2.50 | ||
11/29/2024 | 2.58 | 2.58 | 2.48 | 2.50 | 59,037 | |
11/27/2024 | 2.51 | 2.60 | 2.45 | 2.53 | 50,087 | |
11/26/2024 | 2.64 | 2.64 | 2.45 | 2.48 | 49,234 | |
11/25/2024 | 2.72 | 2.80 | 2.60 | 2.62 | 130,037 | |
11/22/2024 | 2.43 | 2.71 | 2.42 | 2.65 | 124,140 | |
11/21/2024 | 2.42 | 2.59 | 2.38 | 2.50 | 131,568 | |
11/20/2024 | 2.35 | 2.47 | 2.31 | 2.47 | 77,446 | |
11/19/2024 | 2.33 | 2.38 | 2.31 | 2.33 | 30,514 | |
11/18/2024 | 2.35 | 2.40 | 2.27 | 2.33 | 41,769 | |
11/15/2024 | 2.42 | 2.42 | 2.27 | 2.31 | 70,832 | |
11/14/2024 | 2.38 | 2.47 | 2.36 | 2.39 | 39,369 | |
11/13/2024 | 2.43 | 2.51 | 2.40 | 2.43 | 57,458 | |
11/12/2024 | 2.49 | 2.49 | 2.36 | 2.44 | 120,842 | |
11/11/2024 | 2.39 | 2.54 | 2.35 | 2.47 | 142,538 | |
11/08/2024 | 2.28 | 2.36 | 2.26 | 2.32 | 58,826 | |
11/07/2024 | 2.40 | 2.45 | 2.34 | 2.37 | 40,677 | |
11/06/2024 | 2.45 | 2.48 | 2.36 | 2.39 | 69,897 | |
11/05/2024 | 2.43 | 2.60 | 2.26 | 2.48 | 88,827 | |
11/04/2024 | 2.25 | 2.37 | 2.20 | 2.37 | 61,021 | |
11/01/2024 | 2.36 | 2.38 | 2.10 | 2.26 | 66,784 | |
10/31/2024 | 2.59 | 2.59 | 2.31 | 2.37 | 197,751 | |
10/30/2024 | 2.42 | 2.51 | 2.38 | 2.47 | 68,925 | |
10/29/2024 | 2.36 | 2.46 | 2.35 | 2.43 | 89,948 | |
10/28/2024 | 2.42 | 2.44 | 2.33 | 2.39 | 84,156 | |
10/25/2024 | 2.47 | 2.65 | 2.38 | 2.42 | 443,790 | |
10/24/2024 | 2.32 | 2.53 | 2.29 | 2.46 | 375,750 | |
10/23/2024 | 2.41 | 2.49 | 2.32 | 2.37 | 182,609 | |
10/22/2024 | 2.35 | 2.53 | 2.34 | 2.51 | 275,529 | |
10/21/2024 | 2.45 | 2.45 | 2.20 | 2.43 | 489,692 | |
10/18/2024 | 2.80 | 2.83 | 2.40 | 2.54 | 3,156,251 | |
10/17/2024 | 2.43 | 2.70 | 2.40 | 2.65 | 359,856 | |
10/16/2024 | 2.53 | 2.80 | 2.40 | 2.47 | 213,128 | |
10/15/2024 | 2.72 | 2.84 | 2.63 | 2.66 | 132,993 | |
10/14/2024 | 3.00 | 3.00 | 2.61 | 2.76 | 180,517 | |
10/11/2024 | 3.11 | 3.52 | 3.00 | 3.09 | 72,545 | |
10/10/2024 | 3.13 | 3.36 | 3.13 | 3.24 | 46,669 | |
10/09/2024 | 3.02 | 3.45 | 2.84 | 3.23 | 130,858 | |
10/08/2024 | 3.27 | 3.27 | 2.93 | 3.02 | 72,994 | |
10/07/2024 | 3.28 | 3.28 | 2.87 | 3.27 | 116,140 | |
10/04/2024 | 3.71 | 3.75 | 3.15 | 3.29 | 159,259 | |
10/03/2024 | 4.07 | 4.67 | 3.64 | 3.66 | 319,171 | |
10/02/2024 | 4.29 | 4.35 | 3.45 | 4.13 | 556,310 | |
10/01/2024 | 6.21 | 7.67 | 4.22 | 4.47 | 13,510,447 | |
09/30/2024 | 3.74 | 3.93 | 3.47 | 3.54 | 18,131 | |
09/27/2024 | 3.53 | 3.82 | 3.45 | 3.60 | 8,680 | |
09/26/2024 | 3.38 | 3.59 | 3.33 | 3.53 | 5,036 | |
09/25/2024 | 3.45 | 3.58 | 3.34 | 3.42 | 10,072 | |
09/24/2024 | 3.62 | 3.77 | 3.33 | 3.53 | 13,874 | |
09/23/2024 | 3.75 | 3.75 | 3.60 | 3.62 | 6,101 | |
09/20/2024 | 3.72 | 3.90 | 3.60 | 3.75 | 21,540 | |
09/19/2024 | 3.86 | 3.89 | 3.60 | 3.83 | 15,900 | |
09/18/2024 | 3.30 | 3.86 | 3.30 | 3.60 | 13,347 | |
09/17/2024 | 3.90 | 3.95 | 3.68 | 3.71 | 9,729 | |
09/16/2024 | 3.89 | 4.05 | 3.86 | 3.90 | 10,911 | |
09/13/2024 | 3.99 | 4.14 | 3.98 | 4.05 | 12,099 | |
09/12/2024 | 3.97 | 4.20 | 3.91 | 3.95 | 7,453 | |
09/11/2024 | 4.04 | 4.20 | 3.90 | 4.17 | 6,232 | |
09/10/2024 | 4.05 | 4.13 | 3.93 | 4.05 | 15,322 | |
09/09/2024 | 4.03 | 4.20 | 3.91 | 4.18 | 10,993 | |
09/06/2024 | 4.19 | 4.34 | 3.77 | 4.04 | 25,440 |
About Mangoceuticals, Common Stock history
Mangoceuticals, Common investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mangoceuticals, is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mangoceuticals, Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mangoceuticals, Common stock prices may prove useful in developing a viable investing in Mangoceuticals, Common
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 1.4 M | 1.4 M | |
Net Loss | -1.8 M | -1.7 M |
Mangoceuticals, Common Stock Technical Analysis
Mangoceuticals, Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
All Next | Launch Module |
Mangoceuticals, Common Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mangoceuticals, Common's price direction in advance. Along with the technical and fundamental analysis of Mangoceuticals, Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mangoceuticals, to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.23) | |||
Total Risk Alpha | (1.22) | |||
Treynor Ratio | 2.18 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.